Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Envoy Medical ( (COCH) ) has issued an announcement.
On November 26, 2025, Envoy Medical, Inc. held a Special Meeting of Stockholders where stockholders approved the issuance of warrants to purchase shares of Class A Common Stock to comply with Nasdaq Listing Rule 5635(d). Additionally, an administrative proposal allowing adjournments of the meeting was approved but not utilized.
The most recent analyst rating on (COCH) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Envoy Medical stock, see the COCH Stock Forecast page.
Spark’s Take on COCH Stock
According to Spark, TipRanks’ AI Analyst, COCH is a Neutral.
The overall stock score is heavily impacted by the company’s poor financial performance, which is the most significant factor. Technical analysis also indicates bearish momentum, further contributing to the low score. Valuation metrics are unfavorable due to negative earnings and lack of dividends.
To see Spark’s full report on COCH stock, click here.
More about Envoy Medical
Average Trading Volume: 3,003,295
Technical Sentiment Signal: Sell
Current Market Cap: $23.19M
Learn more about COCH stock on TipRanks’ Stock Analysis page.